Literature DB >> 6285345

Impaired receptor-mediated catabolism of low density lipoprotein in the WHHL rabbit, an animal model of familial hypercholesterolemia.

D W Bilheimer, Y Watanabe, T Kita.   

Abstract

The homozygous WHHL (Watanabe heritable hyperlipidemic) rabbit displays either no or only minimal low density lipoprotein (LDL) receptor activity on cultured fibroblasts and liver membranes and has therefore been proposed as an animal model for human familial hypercholesterolemia. To assess the impact of this mutation on LDL metabolism in vivo, we performed lipoprotein turnover studies in normal and WHHL rabbits using both native rabbit LDL and chemically modified LDL (i.e., methyl-LDL) that does not bind to LDL receptors. The total fractional catabolic rate (FCR) for LDL in the normal rabbit was 3.5-fold greater than in the WHHL rabbit. Sixty-seven percent of the total FCR for LDL in the normal rabbit was due to LDL receptor-mediated clearance and 33% was attributable to receptor-independent processes; in the WHHL rabbit, essentially all of the LDL was catabolized via receptor-independent processes. Despite a 17.5-fold elevated plasma pool size of LDL apoprotein (apo-LDL) in WHHL as compared to normal rabbits, the receptor-independent FCR-as judged by the turnover of methyl-LDL-was similar in the two strains. Thus, the receptor-independent catabolic processes are not influenced by the mutation affecting the LDL receptor. The WHHL rabbits also exhibited a 5.6-fold increase in the absolute rate of apo-LDL synthesis and catabolism. In absolute terms, the WHHL rabbit cleared 19-fold more apo-LDL via receptor-independent processes than did the normal rabbit and cleared virtually none by the receptor-dependent pathway. These results indicate that the homozygous WHHL rabbit shares a number of metabolic features in common with human familial hypercholesterolemia and should serve as a useful model for the study of altered lipoprotein metabolism associated with receptor abnormalities. We also noted that the in vivo metabolic behavior of human and rabbit LDL in the normal rabbit differed such that the mean total FCR for human LDL was only 64% of the mean total FCR for rabbit LDL, whereas human and rabbit methyl-LDL were cleared at identical rates. Thus, if human LDL and methyl-LDL had been used in these studies, the magnitude of both the total and receptor-dependent FCR would have been underestimated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6285345      PMCID: PMC346404          DOI: 10.1073/pnas.79.10.3305

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  The theory of tracer experiments with 131I-labelled plasma proteins.

Authors:  C M MATTHEWS
Journal:  Phys Med Biol       Date:  1957-07       Impact factor: 3.609

Review 2.  Kinetic analysis of turnover data.

Authors:  M Berman
Journal:  Prog Biochem Pharmacol       Date:  1979

3.  Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.

Authors:  A F Habeeb
Journal:  Anal Biochem       Date:  1966-03       Impact factor: 3.365

4.  Biochemical characterization of skin fibroblasts derived from WHHL-rabbit, a notable animal model for familial hypercholesterolemia.

Authors:  Y Shimada; K Tanzawa; M Kuroda; Y Tsujita; M Arai; Y Watanabe
Journal:  Eur J Biochem       Date:  1981-09-01

5.  Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia.

Authors:  D W Bilheimer; J L Goldstein; S M Grundy; M S Brown
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

6.  Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins.

Authors:  R W Mahley; T L Innerarity; K B Weisgraber; S Y Oh
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

7.  Accelerated clearance of low-density and high-density lipoproteins and retarded clearance of E apoprotein-containing lipoproteins from the plasma of rats after modification of lysine residues.

Authors:  R W Mahley; K H Weisgraber; T L Innerarity; H G Windmueller
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

8.  Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.

Authors:  D W Bilheimer; N J Stone; S M Grundy
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

9.  Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit).

Authors:  Y Watanabe
Journal:  Atherosclerosis       Date:  1980-06       Impact factor: 5.162

10.  Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys.

Authors:  R W Mahley; K H Weisgraber; G W Melchior; T L Innerarity; K S Holcombe
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

View more
  38 in total

1.  Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes.

Authors:  J M Wilson; N R Chowdhury; M Grossman; R Wajsman; A Epstein; R C Mulligan; J R Chowdhury
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Low-density-lipoprotein receptors in different rabbit liver cells.

Authors:  M S Nenseter; O Myklebost; R Blomhoff; C A Drevon; A Nilsson; K R Norum; T Berg
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

3.  Receptor-independent low density lipoprotein transport in the rat in vivo. Quantitation, characterization, and metabolic consequences.

Authors:  D K Spady; S D Turley; J M Dietschy
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

4.  Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster.

Authors:  D K Spady; J M Dietschy
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

5.  High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

6.  Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits.

Authors:  T Kita; M S Brown; D W Bilheimer; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

Authors:  D W Bilheimer; S M Grundy; M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

8.  Antiatherogenic effects of the antioxidant BO-653 in three different animal models.

Authors:  O Cynshi; Y Kawabe; T Suzuki; Y Takashima; H Kaise; M Nakamura; Y Ohba; Y Kato; K Tamura; A Hayasaka; A Higashida; H Sakaguchi; M Takeya; K Takahashi; K Inoue; N Noguchi; E Niki; T Kodama
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

9.  Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy. II. In vivo validation, LDL receptor-dependent and unspecific hepatic uptake and scintigraphic results.

Authors:  T Leitha; A Staudenherz; B Gmeiner; M Hermann; M Hüttinger; R Dudczak
Journal:  Eur J Nucl Med       Date:  1993-08

10.  Use of monoclonal anti-receptor antibodies to probe the expression of the low density lipoprotein receptor in tissues of normal and Watanabe heritable hyperlipidemic rabbits.

Authors:  M Huettinger; W J Schneider; Y K Ho; J L Goldstein; M S Brown
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.